42
Views
0
CrossRef citations to date
0
Altmetric
Commentary

New Opportunities for Treatment and Prevention of Neurodegenerative Diseases With PTP1B Inhibitors

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1443-1447 | Received 29 Jun 2023, Accepted 01 Aug 2023, Published online: 23 Aug 2023
 

Author contributions

D Kołodziej: conceptualization, investigation, methodology, writing (original draft, review and editing); Ł Sobczak: investigation, writing (review and editing); KZ Łączkowski: supervision, writing (review and editing).

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.